The FDA would be allowed to collect at least $1.78 billion in user fees over five years under a reauthorization of the medical device user fee program, according to a series of recommendations from the agency and representatives from the medical device industry released March 22.
Read the full post on Becker's Hospital Review - Healthcare News
